View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
June 23, 2020

MOD funds predictive sepsis test for Covid-19 patients

By Chloe Kent

Defence Science and Technology Laboratory (DSTL) spinout Ploughshare Innovations has awarded £200,000 to Presymptom Health for the development of a test to predict whether Covid-19 patients will develop sepsis before symptoms appear.

The sepsis research is based on ten years of work done at DSTL. The research suggests that the test will be able to determine whether a patient will develop sepsis up to three days before becoming symptomatic.

Six months will now be spent developing the prototype diagnostic test, trialling the device on Covid-19 patients and testing samples from the DSTL biobank.

Topics in this article: , , ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU